A Phase 1-2 Multi-Center Dose Escalation Study of a Single Dose of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease
Study on the Effects of an Investigational Medication for Chronic Pain Management
Not Recruiting
18 years - 100 years
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Chronic Kidney Disease
Age:
18 years - 100 years
Gender: All
Who can participate: Adults aged 18-65 with a diagnosis of chronic pain for at least six months are eligible to participate. Participants should not have any significant health issues that might interfere with the study results.
Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo, which is a substance with no active therapeutic effect, to compare outcomes. The study will involve regular assessments of pain levels and any side effects experienced.
Updated on
19 Feb 2024.
Study ID: 0909-20 (1011003905)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
